As the scale of Pune’s Guillain-Barré Syndrome (GBS) outbreak grows, with the number of cases rising to 101, there is much curiosity around the prognosis and treatment of the rare condition. Speaking ...
Please provide your email address to receive an email when new articles are posted on . Results from a phase 2 clinical trial showed that treatment with an IgG-cleaving enzyme for individuals ...
First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback